AI is designing proteins that could help treat cancer
SMRTR summary
Scientists have developed an AI-powered "GPS" system for cancer-fighting immune cells. The system uses custom-designed proteins to guide T cells towards cancer targets, potentially improving immunotherapy treatments. In lab experiments, engineered T cells with these AI-designed proteins successfully killed melanoma cells and prevented cancer growth. This approach could lead to faster development of personalized cancer therapies and may have applications beyond oncology. While still in early stages, the research demonstrates the potential of AI in creating new medical treatments.
SMRTR provides this summary for quick context. The original article belongs to Science News.
Read the original article